nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—migraine—Prednisone—hematologic cancer	0.465	1	CpDpCtD
Zolmitriptan—CYP1A2—Anagrelide—hematologic cancer	0.0505	0.217	CbGbCtD
Zolmitriptan—CYP1A2—Carmustine—hematologic cancer	0.0265	0.114	CbGbCtD
Zolmitriptan—CYP1A2—Methoxsalen—hematologic cancer	0.0225	0.0969	CbGbCtD
Zolmitriptan—CYP1A2—Bortezomib—hematologic cancer	0.0214	0.0922	CbGbCtD
Zolmitriptan—CYP1A2—Daunorubicin—hematologic cancer	0.0205	0.0882	CbGbCtD
Zolmitriptan—CYP1A2—Alitretinoin—hematologic cancer	0.0201	0.0864	CbGbCtD
Zolmitriptan—CYP1A2—Thalidomide—hematologic cancer	0.0187	0.0803	CbGbCtD
Zolmitriptan—CYP1A2—Dacarbazine—hematologic cancer	0.0161	0.0691	CbGbCtD
Zolmitriptan—CYP1A2—Imatinib—hematologic cancer	0.0157	0.0676	CbGbCtD
Zolmitriptan—CYP1A2—Dasatinib—hematologic cancer	0.0126	0.0543	CbGbCtD
Zolmitriptan—CYP1A2—Etoposide—hematologic cancer	0.00786	0.0338	CbGbCtD
Zolmitriptan—Melatonin—CALR—hematologic cancer	0.00192	0.582	CrCbGaD
Zolmitriptan—Sumatriptan—ABCG2—hematologic cancer	0.000411	0.125	CrCbGaD
Zolmitriptan—Melatonin—MPO—hematologic cancer	0.000377	0.114	CrCbGaD
Zolmitriptan—Melatonin—ESR1—hematologic cancer	0.000283	0.0857	CrCbGaD
Zolmitriptan—Sumatriptan—ABCB1—hematologic cancer	0.000171	0.0519	CrCbGaD
Zolmitriptan—Eletriptan—ABCB1—hematologic cancer	0.000138	0.042	CrCbGaD
Zolmitriptan—Shock—Prednisone—hematologic cancer	1.99e-05	7.96e-05	CcSEcCtD
Zolmitriptan—Arrhythmia—Epirubicin—hematologic cancer	1.99e-05	7.96e-05	CcSEcCtD
Zolmitriptan—Pain—Betamethasone—hematologic cancer	1.98e-05	7.95e-05	CcSEcCtD
Zolmitriptan—Pain—Dexamethasone—hematologic cancer	1.98e-05	7.95e-05	CcSEcCtD
Zolmitriptan—Nervous system disorder—Prednisone—hematologic cancer	1.98e-05	7.94e-05	CcSEcCtD
Zolmitriptan—Tachycardia—Prednisone—hematologic cancer	1.97e-05	7.9e-05	CcSEcCtD
Zolmitriptan—Skin disorder—Prednisone—hematologic cancer	1.96e-05	7.86e-05	CcSEcCtD
Zolmitriptan—Nausea—Gemcitabine—hematologic cancer	1.96e-05	7.86e-05	CcSEcCtD
Zolmitriptan—Vomiting—Cisplatin—hematologic cancer	1.95e-05	7.84e-05	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Prednisone—hematologic cancer	1.95e-05	7.82e-05	CcSEcCtD
Zolmitriptan—Rash—Cisplatin—hematologic cancer	1.94e-05	7.77e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Cisplatin—hematologic cancer	1.94e-05	7.77e-05	CcSEcCtD
Zolmitriptan—Erythema—Epirubicin—hematologic cancer	1.93e-05	7.76e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Etoposide—hematologic cancer	1.93e-05	7.73e-05	CcSEcCtD
Zolmitriptan—Anorexia—Prednisone—hematologic cancer	1.92e-05	7.72e-05	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Methotrexate—hematologic cancer	1.92e-05	7.69e-05	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—hematologic cancer	1.92e-05	7.69e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Betamethasone—hematologic cancer	1.91e-05	7.66e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Dexamethasone—hematologic cancer	1.91e-05	7.66e-05	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—hematologic cancer	1.91e-05	7.65e-05	CcSEcCtD
Zolmitriptan—Tension—Epirubicin—hematologic cancer	1.9e-05	7.61e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.9e-05	7.6e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Betamethasone—hematologic cancer	1.9e-05	7.6e-05	CcSEcCtD
Zolmitriptan—Dysgeusia—Epirubicin—hematologic cancer	1.89e-05	7.6e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Triamcinolone—hematologic cancer	1.88e-05	7.55e-05	CcSEcCtD
Zolmitriptan—Nervousness—Epirubicin—hematologic cancer	1.88e-05	7.53e-05	CcSEcCtD
Zolmitriptan—Back pain—Epirubicin—hematologic cancer	1.87e-05	7.5e-05	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—hematologic cancer	1.87e-05	7.48e-05	CcSEcCtD
Zolmitriptan—Malaise—Methotrexate—hematologic cancer	1.86e-05	7.47e-05	CcSEcCtD
Zolmitriptan—Dizziness—Etoposide—hematologic cancer	1.86e-05	7.47e-05	CcSEcCtD
Zolmitriptan—Muscle spasms—Epirubicin—hematologic cancer	1.86e-05	7.46e-05	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—hematologic cancer	1.86e-05	7.45e-05	CcSEcCtD
Zolmitriptan—Vertigo—Methotrexate—hematologic cancer	1.86e-05	7.45e-05	CcSEcCtD
Zolmitriptan—Leukopenia—Methotrexate—hematologic cancer	1.85e-05	7.42e-05	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—hematologic cancer	1.85e-05	7.4e-05	CcSEcCtD
Zolmitriptan—Urticaria—Betamethasone—hematologic cancer	1.84e-05	7.38e-05	CcSEcCtD
Zolmitriptan—Urticaria—Dexamethasone—hematologic cancer	1.84e-05	7.38e-05	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.84e-05	7.37e-05	CcSEcCtD
Zolmitriptan—Dizziness—Prednisolone—hematologic cancer	1.84e-05	7.37e-05	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—hematologic cancer	1.84e-05	7.37e-05	CcSEcCtD
Zolmitriptan—Asthenia—Triamcinolone—hematologic cancer	1.83e-05	7.35e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Dexamethasone—hematologic cancer	1.83e-05	7.35e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Betamethasone—hematologic cancer	1.83e-05	7.35e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Betamethasone—hematologic cancer	1.83e-05	7.35e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Dexamethasone—hematologic cancer	1.83e-05	7.35e-05	CcSEcCtD
Zolmitriptan—Nausea—Cisplatin—hematologic cancer	1.83e-05	7.32e-05	CcSEcCtD
Zolmitriptan—Insomnia—Prednisone—hematologic cancer	1.83e-05	7.32e-05	CcSEcCtD
Zolmitriptan—Paraesthesia—Prednisone—hematologic cancer	1.81e-05	7.27e-05	CcSEcCtD
Zolmitriptan—Pruritus—Triamcinolone—hematologic cancer	1.81e-05	7.25e-05	CcSEcCtD
Zolmitriptan—Cough—Methotrexate—hematologic cancer	1.8e-05	7.23e-05	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Epirubicin—hematologic cancer	1.8e-05	7.2e-05	CcSEcCtD
Zolmitriptan—Convulsion—Methotrexate—hematologic cancer	1.79e-05	7.18e-05	CcSEcCtD
Zolmitriptan—Vomiting—Etoposide—hematologic cancer	1.79e-05	7.18e-05	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—hematologic cancer	1.79e-05	7.18e-05	CcSEcCtD
Zolmitriptan—Agitation—Epirubicin—hematologic cancer	1.78e-05	7.13e-05	CcSEcCtD
Zolmitriptan—Dyspepsia—Prednisone—hematologic cancer	1.78e-05	7.12e-05	CcSEcCtD
Zolmitriptan—Rash—Etoposide—hematologic cancer	1.78e-05	7.12e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Etoposide—hematologic cancer	1.77e-05	7.11e-05	CcSEcCtD
Zolmitriptan—Headache—Etoposide—hematologic cancer	1.76e-05	7.07e-05	CcSEcCtD
Zolmitriptan—Myalgia—Methotrexate—hematologic cancer	1.76e-05	7.06e-05	CcSEcCtD
Zolmitriptan—Chest pain—Methotrexate—hematologic cancer	1.76e-05	7.06e-05	CcSEcCtD
Zolmitriptan—Arthralgia—Methotrexate—hematologic cancer	1.76e-05	7.06e-05	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—hematologic cancer	1.76e-05	7.04e-05	CcSEcCtD
Zolmitriptan—Decreased appetite—Prednisone—hematologic cancer	1.75e-05	7.04e-05	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—hematologic cancer	1.75e-05	7.03e-05	CcSEcCtD
Zolmitriptan—Rash—Prednisolone—hematologic cancer	1.75e-05	7.02e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Prednisolone—hematologic cancer	1.75e-05	7.02e-05	CcSEcCtD
Zolmitriptan—Malaise—Epirubicin—hematologic cancer	1.74e-05	6.99e-05	CcSEcCtD
Zolmitriptan—Headache—Prednisolone—hematologic cancer	1.74e-05	6.98e-05	CcSEcCtD
Zolmitriptan—Discomfort—Methotrexate—hematologic cancer	1.74e-05	6.97e-05	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—hematologic cancer	1.74e-05	6.97e-05	CcSEcCtD
Zolmitriptan—Vertigo—Epirubicin—hematologic cancer	1.74e-05	6.97e-05	CcSEcCtD
Zolmitriptan—Syncope—Epirubicin—hematologic cancer	1.73e-05	6.96e-05	CcSEcCtD
Zolmitriptan—Leukopenia—Epirubicin—hematologic cancer	1.73e-05	6.94e-05	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—hematologic cancer	1.73e-05	6.94e-05	CcSEcCtD
Zolmitriptan—Constipation—Prednisone—hematologic cancer	1.73e-05	6.92e-05	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—hematologic cancer	1.72e-05	6.9e-05	CcSEcCtD
Zolmitriptan—Palpitations—Epirubicin—hematologic cancer	1.71e-05	6.85e-05	CcSEcCtD
Zolmitriptan—Confusional state—Methotrexate—hematologic cancer	1.7e-05	6.82e-05	CcSEcCtD
Zolmitriptan—Loss of consciousness—Epirubicin—hematologic cancer	1.7e-05	6.82e-05	CcSEcCtD
Zolmitriptan—Dizziness—Triamcinolone—hematologic cancer	1.69e-05	6.77e-05	CcSEcCtD
Zolmitriptan—Cough—Epirubicin—hematologic cancer	1.69e-05	6.77e-05	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Methotrexate—hematologic cancer	1.69e-05	6.76e-05	CcSEcCtD
Zolmitriptan—Convulsion—Epirubicin—hematologic cancer	1.68e-05	6.72e-05	CcSEcCtD
Zolmitriptan—Infection—Methotrexate—hematologic cancer	1.68e-05	6.72e-05	CcSEcCtD
Zolmitriptan—Nausea—Etoposide—hematologic cancer	1.67e-05	6.71e-05	CcSEcCtD
Zolmitriptan—Hypertension—Epirubicin—hematologic cancer	1.67e-05	6.7e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Prednisone—hematologic cancer	1.66e-05	6.67e-05	CcSEcCtD
Zolmitriptan—Asthenia—Dexamethasone—hematologic cancer	1.66e-05	6.67e-05	CcSEcCtD
Zolmitriptan—Asthenia—Betamethasone—hematologic cancer	1.66e-05	6.67e-05	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—hematologic cancer	1.66e-05	6.66e-05	CcSEcCtD
Zolmitriptan—Nervous system disorder—Methotrexate—hematologic cancer	1.65e-05	6.63e-05	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Methotrexate—hematologic cancer	1.65e-05	6.62e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Prednisone—hematologic cancer	1.65e-05	6.62e-05	CcSEcCtD
Zolmitriptan—Nausea—Prednisolone—hematologic cancer	1.65e-05	6.62e-05	CcSEcCtD
Zolmitriptan—Myalgia—Epirubicin—hematologic cancer	1.65e-05	6.6e-05	CcSEcCtD
Zolmitriptan—Arthralgia—Epirubicin—hematologic cancer	1.65e-05	6.6e-05	CcSEcCtD
Zolmitriptan—Chest pain—Epirubicin—hematologic cancer	1.65e-05	6.6e-05	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—hematologic cancer	1.65e-05	6.6e-05	CcSEcCtD
Zolmitriptan—Anxiety—Epirubicin—hematologic cancer	1.64e-05	6.58e-05	CcSEcCtD
Zolmitriptan—Pruritus—Betamethasone—hematologic cancer	1.64e-05	6.58e-05	CcSEcCtD
Zolmitriptan—Pruritus—Dexamethasone—hematologic cancer	1.64e-05	6.58e-05	CcSEcCtD
Zolmitriptan—Skin disorder—Methotrexate—hematologic cancer	1.64e-05	6.57e-05	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Methotrexate—hematologic cancer	1.63e-05	6.54e-05	CcSEcCtD
Zolmitriptan—Discomfort—Epirubicin—hematologic cancer	1.63e-05	6.52e-05	CcSEcCtD
Zolmitriptan—Vomiting—Triamcinolone—hematologic cancer	1.62e-05	6.51e-05	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—hematologic cancer	1.61e-05	6.47e-05	CcSEcCtD
Zolmitriptan—Rash—Triamcinolone—hematologic cancer	1.61e-05	6.46e-05	CcSEcCtD
Zolmitriptan—Dry mouth—Epirubicin—hematologic cancer	1.61e-05	6.46e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Triamcinolone—hematologic cancer	1.61e-05	6.45e-05	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—hematologic cancer	1.61e-05	6.45e-05	CcSEcCtD
Zolmitriptan—Anorexia—Methotrexate—hematologic cancer	1.61e-05	6.45e-05	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—hematologic cancer	1.61e-05	6.44e-05	CcSEcCtD
Zolmitriptan—Urticaria—Prednisone—hematologic cancer	1.6e-05	6.43e-05	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—hematologic cancer	1.6e-05	6.42e-05	CcSEcCtD
Zolmitriptan—Headache—Triamcinolone—hematologic cancer	1.6e-05	6.42e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Prednisone—hematologic cancer	1.6e-05	6.4e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Prednisone—hematologic cancer	1.6e-05	6.4e-05	CcSEcCtD
Zolmitriptan—Confusional state—Epirubicin—hematologic cancer	1.59e-05	6.38e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Betamethasone—hematologic cancer	1.59e-05	6.36e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Dexamethasone—hematologic cancer	1.59e-05	6.36e-05	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—hematologic cancer	1.58e-05	6.34e-05	CcSEcCtD
Zolmitriptan—Oedema—Epirubicin—hematologic cancer	1.58e-05	6.33e-05	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Epirubicin—hematologic cancer	1.58e-05	6.33e-05	CcSEcCtD
Zolmitriptan—Loss of consciousness—Doxorubicin—hematologic cancer	1.57e-05	6.31e-05	CcSEcCtD
Zolmitriptan—Infection—Epirubicin—hematologic cancer	1.57e-05	6.29e-05	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—hematologic cancer	1.56e-05	6.26e-05	CcSEcCtD
Zolmitriptan—Shock—Epirubicin—hematologic cancer	1.55e-05	6.23e-05	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—hematologic cancer	1.55e-05	6.22e-05	CcSEcCtD
Zolmitriptan—Nervous system disorder—Epirubicin—hematologic cancer	1.55e-05	6.21e-05	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Epirubicin—hematologic cancer	1.55e-05	6.2e-05	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—hematologic cancer	1.55e-05	6.2e-05	CcSEcCtD
Zolmitriptan—Tachycardia—Epirubicin—hematologic cancer	1.54e-05	6.18e-05	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.54e-05	6.16e-05	CcSEcCtD
Zolmitriptan—Skin disorder—Epirubicin—hematologic cancer	1.53e-05	6.15e-05	CcSEcCtD
Zolmitriptan—Dizziness—Betamethasone—hematologic cancer	1.53e-05	6.15e-05	CcSEcCtD
Zolmitriptan—Dizziness—Dexamethasone—hematologic cancer	1.53e-05	6.15e-05	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Epirubicin—hematologic cancer	1.53e-05	6.12e-05	CcSEcCtD
Zolmitriptan—Insomnia—Methotrexate—hematologic cancer	1.53e-05	6.12e-05	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—hematologic cancer	1.52e-05	6.11e-05	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—hematologic cancer	1.52e-05	6.11e-05	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—hematologic cancer	1.52e-05	6.11e-05	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—hematologic cancer	1.52e-05	6.09e-05	CcSEcCtD
Zolmitriptan—Nausea—Triamcinolone—hematologic cancer	1.52e-05	6.08e-05	CcSEcCtD
Zolmitriptan—Paraesthesia—Methotrexate—hematologic cancer	1.51e-05	6.07e-05	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—hematologic cancer	1.51e-05	6.04e-05	CcSEcCtD
Zolmitriptan—Anorexia—Epirubicin—hematologic cancer	1.51e-05	6.03e-05	CcSEcCtD
Zolmitriptan—Dyspnoea—Methotrexate—hematologic cancer	1.5e-05	6.03e-05	CcSEcCtD
Zolmitriptan—Somnolence—Methotrexate—hematologic cancer	1.5e-05	6.01e-05	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—hematologic cancer	1.49e-05	5.98e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Prednisone—hematologic cancer	1.49e-05	5.96e-05	CcSEcCtD
Zolmitriptan—Dyspepsia—Methotrexate—hematologic cancer	1.49e-05	5.95e-05	CcSEcCtD
Zolmitriptan—Vomiting—Dexamethasone—hematologic cancer	1.47e-05	5.91e-05	CcSEcCtD
Zolmitriptan—Vomiting—Betamethasone—hematologic cancer	1.47e-05	5.91e-05	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—hematologic cancer	1.47e-05	5.91e-05	CcSEcCtD
Zolmitriptan—Decreased appetite—Methotrexate—hematologic cancer	1.47e-05	5.88e-05	CcSEcCtD
Zolmitriptan—Rash—Betamethasone—hematologic cancer	1.46e-05	5.86e-05	CcSEcCtD
Zolmitriptan—Rash—Dexamethasone—hematologic cancer	1.46e-05	5.86e-05	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—hematologic cancer	1.46e-05	5.86e-05	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—hematologic cancer	1.46e-05	5.86e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Betamethasone—hematologic cancer	1.46e-05	5.85e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Dexamethasone—hematologic cancer	1.46e-05	5.85e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.46e-05	5.84e-05	CcSEcCtD
Zolmitriptan—Headache—Betamethasone—hematologic cancer	1.45e-05	5.82e-05	CcSEcCtD
Zolmitriptan—Headache—Dexamethasone—hematologic cancer	1.45e-05	5.82e-05	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—hematologic cancer	1.45e-05	5.82e-05	CcSEcCtD
Zolmitriptan—Asthenia—Prednisone—hematologic cancer	1.45e-05	5.81e-05	CcSEcCtD
Zolmitriptan—Pain—Methotrexate—hematologic cancer	1.44e-05	5.78e-05	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.44e-05	5.77e-05	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—hematologic cancer	1.44e-05	5.76e-05	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—hematologic cancer	1.43e-05	5.74e-05	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—hematologic cancer	1.43e-05	5.74e-05	CcSEcCtD
Zolmitriptan—Pruritus—Prednisone—hematologic cancer	1.43e-05	5.73e-05	CcSEcCtD
Zolmitriptan—Insomnia—Epirubicin—hematologic cancer	1.43e-05	5.73e-05	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—hematologic cancer	1.43e-05	5.72e-05	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—hematologic cancer	1.42e-05	5.69e-05	CcSEcCtD
Zolmitriptan—Paraesthesia—Epirubicin—hematologic cancer	1.42e-05	5.68e-05	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—hematologic cancer	1.41e-05	5.66e-05	CcSEcCtD
Zolmitriptan—Dyspnoea—Epirubicin—hematologic cancer	1.41e-05	5.64e-05	CcSEcCtD
Zolmitriptan—Somnolence—Epirubicin—hematologic cancer	1.4e-05	5.63e-05	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—hematologic cancer	1.39e-05	5.58e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Methotrexate—hematologic cancer	1.39e-05	5.57e-05	CcSEcCtD
Zolmitriptan—Dyspepsia—Epirubicin—hematologic cancer	1.39e-05	5.57e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Prednisone—hematologic cancer	1.38e-05	5.54e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Methotrexate—hematologic cancer	1.38e-05	5.53e-05	CcSEcCtD
Zolmitriptan—Nausea—Dexamethasone—hematologic cancer	1.38e-05	5.52e-05	CcSEcCtD
Zolmitriptan—Nausea—Betamethasone—hematologic cancer	1.38e-05	5.52e-05	CcSEcCtD
Zolmitriptan—Decreased appetite—Epirubicin—hematologic cancer	1.37e-05	5.5e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.36e-05	5.47e-05	CcSEcCtD
Zolmitriptan—Constipation—Epirubicin—hematologic cancer	1.35e-05	5.41e-05	CcSEcCtD
Zolmitriptan—Pain—Epirubicin—hematologic cancer	1.35e-05	5.41e-05	CcSEcCtD
Zolmitriptan—Urticaria—Methotrexate—hematologic cancer	1.34e-05	5.37e-05	CcSEcCtD
Zolmitriptan—Dizziness—Prednisone—hematologic cancer	1.33e-05	5.35e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Methotrexate—hematologic cancer	1.33e-05	5.35e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Methotrexate—hematologic cancer	1.33e-05	5.35e-05	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.33e-05	5.34e-05	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—hematologic cancer	1.32e-05	5.3e-05	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—hematologic cancer	1.31e-05	5.26e-05	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—hematologic cancer	1.3e-05	5.22e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Epirubicin—hematologic cancer	1.3e-05	5.22e-05	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—hematologic cancer	1.3e-05	5.21e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Epirubicin—hematologic cancer	1.29e-05	5.18e-05	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—hematologic cancer	1.29e-05	5.16e-05	CcSEcCtD
Zolmitriptan—Vomiting—Prednisone—hematologic cancer	1.28e-05	5.15e-05	CcSEcCtD
Zolmitriptan—Rash—Prednisone—hematologic cancer	1.27e-05	5.1e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Prednisone—hematologic cancer	1.27e-05	5.1e-05	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—hematologic cancer	1.27e-05	5.09e-05	CcSEcCtD
Zolmitriptan—Headache—Prednisone—hematologic cancer	1.26e-05	5.07e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.26e-05	5.06e-05	CcSEcCtD
Zolmitriptan—Urticaria—Epirubicin—hematologic cancer	1.25e-05	5.03e-05	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—hematologic cancer	1.25e-05	5.01e-05	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—hematologic cancer	1.25e-05	5.01e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Epirubicin—hematologic cancer	1.25e-05	5e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Epirubicin—hematologic cancer	1.25e-05	5e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Methotrexate—hematologic cancer	1.24e-05	4.98e-05	CcSEcCtD
Zolmitriptan—Asthenia—Methotrexate—hematologic cancer	1.21e-05	4.85e-05	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—hematologic cancer	1.2e-05	4.83e-05	CcSEcCtD
Zolmitriptan—Nausea—Prednisone—hematologic cancer	1.2e-05	4.81e-05	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.19e-05	4.79e-05	CcSEcCtD
Zolmitriptan—Pruritus—Methotrexate—hematologic cancer	1.19e-05	4.79e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Epirubicin—hematologic cancer	1.16e-05	4.66e-05	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—hematologic cancer	1.16e-05	4.65e-05	CcSEcCtD
Zolmitriptan—Abdominal pain—Doxorubicin—hematologic cancer	1.15e-05	4.63e-05	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—hematologic cancer	1.15e-05	4.63e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Methotrexate—hematologic cancer	1.15e-05	4.63e-05	CcSEcCtD
Zolmitriptan—Asthenia—Epirubicin—hematologic cancer	1.13e-05	4.54e-05	CcSEcCtD
Zolmitriptan—Pruritus—Epirubicin—hematologic cancer	1.12e-05	4.48e-05	CcSEcCtD
Zolmitriptan—Dizziness—Methotrexate—hematologic cancer	1.12e-05	4.47e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Epirubicin—hematologic cancer	1.08e-05	4.33e-05	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—hematologic cancer	1.08e-05	4.32e-05	CcSEcCtD
Zolmitriptan—Vomiting—Methotrexate—hematologic cancer	1.07e-05	4.3e-05	CcSEcCtD
Zolmitriptan—Rash—Methotrexate—hematologic cancer	1.06e-05	4.27e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Methotrexate—hematologic cancer	1.06e-05	4.26e-05	CcSEcCtD
Zolmitriptan—Headache—Methotrexate—hematologic cancer	1.06e-05	4.24e-05	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—hematologic cancer	1.05e-05	4.2e-05	CcSEcCtD
Zolmitriptan—Dizziness—Epirubicin—hematologic cancer	1.04e-05	4.19e-05	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—hematologic cancer	1.03e-05	4.14e-05	CcSEcCtD
Zolmitriptan—Vomiting—Epirubicin—hematologic cancer	1e-05	4.03e-05	CcSEcCtD
Zolmitriptan—Nausea—Methotrexate—hematologic cancer	1e-05	4.02e-05	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—hematologic cancer	1e-05	4.01e-05	CcSEcCtD
Zolmitriptan—Rash—Epirubicin—hematologic cancer	9.96e-06	3.99e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Epirubicin—hematologic cancer	9.95e-06	3.99e-05	CcSEcCtD
Zolmitriptan—Headache—Epirubicin—hematologic cancer	9.89e-06	3.97e-05	CcSEcCtD
Zolmitriptan—Dizziness—Doxorubicin—hematologic cancer	9.66e-06	3.87e-05	CcSEcCtD
Zolmitriptan—Nausea—Epirubicin—hematologic cancer	9.38e-06	3.76e-05	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—hematologic cancer	9.29e-06	3.72e-05	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—hematologic cancer	9.21e-06	3.69e-05	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—hematologic cancer	9.2e-06	3.69e-05	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—hematologic cancer	9.15e-06	3.67e-05	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—hematologic cancer	8.68e-06	3.48e-05	CcSEcCtD
Zolmitriptan—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.63e-06	0.000133	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—hematologic cancer	6.59e-06	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3R1—hematologic cancer	6.58e-06	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FN1—hematologic cancer	6.56e-06	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1A—hematologic cancer	6.52e-06	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ESR1—hematologic cancer	6.5e-06	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTEN—hematologic cancer	6.5e-06	0.000131	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.48e-06	0.00013	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKBIA—hematologic cancer	6.48e-06	0.00013	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BAD—hematologic cancer	6.48e-06	0.00013	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CD86—hematologic cancer	6.43e-06	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FN1—hematologic cancer	6.42e-06	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH1—hematologic cancer	6.42e-06	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—JAK2—hematologic cancer	6.4e-06	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK8—hematologic cancer	6.36e-06	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BAD—hematologic cancer	6.35e-06	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKBIA—hematologic cancer	6.35e-06	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HES1—hematologic cancer	6.34e-06	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—hematologic cancer	6.34e-06	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NCOR1—hematologic cancer	6.31e-06	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CD80—hematologic cancer	6.29e-06	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH1—hematologic cancer	6.29e-06	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIT—hematologic cancer	6.28e-06	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—hematologic cancer	6.28e-06	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NRAS—hematologic cancer	6.28e-06	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF1—hematologic cancer	6.24e-06	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CSF2—hematologic cancer	6.24e-06	0.000125	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.23e-06	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EP300—hematologic cancer	6.2e-06	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTPN11—hematologic cancer	6.17e-06	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CD80—hematologic cancer	6.16e-06	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIT—hematologic cancer	6.15e-06	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—hematologic cancer	6.15e-06	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NRAS—hematologic cancer	6.15e-06	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FOXO1—hematologic cancer	6.15e-06	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—hematologic cancer	6.14e-06	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFRB—hematologic cancer	6.14e-06	0.000123	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CREBBP—hematologic cancer	6.11e-06	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CB—hematologic cancer	6.07e-06	0.000122	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.06e-06	0.000122	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.06e-06	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTPN11—hematologic cancer	6.04e-06	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFRA—hematologic cancer	6.04e-06	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SRC—hematologic cancer	6.03e-06	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAK1—hematologic cancer	6.02e-06	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCG—hematologic cancer	6.02e-06	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MAPK3—hematologic cancer	6.01e-06	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CREB1—hematologic cancer	5.98e-06	0.00012	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.91e-06	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—hematologic cancer	5.9e-06	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MAPK3—hematologic cancer	5.89e-06	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—hematologic cancer	5.87e-06	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CREB1—hematologic cancer	5.85e-06	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL2—hematologic cancer	5.85e-06	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6R—hematologic cancer	5.83e-06	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CREBBP—hematologic cancer	5.82e-06	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—hematologic cancer	5.81e-06	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NRAS—hematologic cancer	5.8e-06	0.000116	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CD—hematologic cancer	5.79e-06	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—hematologic cancer	5.78e-06	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL2—hematologic cancer	5.73e-06	0.000115	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NUP98—hematologic cancer	5.72e-06	0.000115	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—hematologic cancer	5.72e-06	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6R—hematologic cancer	5.71e-06	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CREBBP—hematologic cancer	5.7e-06	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2RA—hematologic cancer	5.62e-06	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—hematologic cancer	5.58e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—hematologic cancer	5.56e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAP2K1—hematologic cancer	5.56e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK3—hematologic cancer	5.55e-06	0.000112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.55e-06	0.000112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.55e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CD—hematologic cancer	5.52e-06	0.000111	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NUP214—hematologic cancer	5.51e-06	0.000111	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3R1—hematologic cancer	5.47e-06	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—hematologic cancer	5.47e-06	0.00011	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.46e-06	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAP2K1—hematologic cancer	5.44e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	5.43e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CD—hematologic cancer	5.4e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—hematologic cancer	5.4e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—hematologic cancer	5.4e-06	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTR—hematologic cancer	5.4e-06	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.4e-06	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—hematologic cancer	5.39e-06	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	5.35e-06	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSC2—hematologic cancer	5.3e-06	0.000106	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ENO2—hematologic cancer	5.3e-06	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—hematologic cancer	5.29e-06	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGF2—hematologic cancer	5.28e-06	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3R1—hematologic cancer	5.21e-06	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGF2—hematologic cancer	5.17e-06	0.000104	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.14e-06	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3R1—hematologic cancer	5.1e-06	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	5.1e-06	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JAK2—hematologic cancer	5.07e-06	0.000102	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.06e-06	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	5.05e-06	0.000101	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CB—hematologic cancer	5.05e-06	0.000101	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SDC1—hematologic cancer	5.02e-06	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—hematologic cancer	4.99e-06	0.0001	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—hematologic cancer	4.96e-06	9.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JAK2—hematologic cancer	4.96e-06	9.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ESR1—hematologic cancer	4.95e-06	9.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MDM2—hematologic cancer	4.94e-06	9.93e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FN1—hematologic cancer	4.89e-06	9.83e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—hematologic cancer	4.86e-06	9.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MDM2—hematologic cancer	4.84e-06	9.72e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BAD—hematologic cancer	4.84e-06	9.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	4.84e-06	9.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CB—hematologic cancer	4.81e-06	9.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MTOR—hematologic cancer	4.81e-06	9.66e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.8e-06	9.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	4.79e-06	9.62e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.74e-06	9.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MTOR—hematologic cancer	4.71e-06	9.46e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CB—hematologic cancer	4.71e-06	9.46e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CD80—hematologic cancer	4.69e-06	9.42e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	4.68e-06	9.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIT—hematologic cancer	4.68e-06	9.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	4.68e-06	9.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	4.6e-06	9.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HRAS—hematologic cancer	4.59e-06	9.22e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—hematologic cancer	4.59e-06	9.21e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.53e-06	9.1e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1B—hematologic cancer	4.52e-06	9.07e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HRAS—hematologic cancer	4.5e-06	9.03e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	4.49e-06	9.01e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—hematologic cancer	4.47e-06	8.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CREB1—hematologic cancer	4.46e-06	8.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—hematologic cancer	4.44e-06	8.91e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—hematologic cancer	4.43e-06	8.89e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1B—hematologic cancer	4.42e-06	8.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—hematologic cancer	4.42e-06	8.87e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—hematologic cancer	4.4e-06	8.84e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—hematologic cancer	4.4e-06	8.83e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—hematologic cancer	4.37e-06	8.78e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTEN—hematologic cancer	4.36e-06	8.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL2—hematologic cancer	4.36e-06	8.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6R—hematologic cancer	4.35e-06	8.73e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	4.34e-06	8.72e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—hematologic cancer	4.33e-06	8.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—hematologic cancer	4.33e-06	8.69e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—hematologic cancer	4.31e-06	8.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—hematologic cancer	4.3e-06	8.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JUN—hematologic cancer	4.3e-06	8.63e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NQO1—hematologic cancer	4.27e-06	8.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD44—hematologic cancer	4.27e-06	8.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HRAS—hematologic cancer	4.24e-06	8.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—hematologic cancer	4.22e-06	8.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JUN—hematologic cancer	4.21e-06	8.45e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.18e-06	8.4e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1A—hematologic cancer	4.17e-06	8.37e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—EP300—hematologic cancer	4.16e-06	8.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTEN—hematologic cancer	4.16e-06	8.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	4.14e-06	8.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	4.12e-06	8.27e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1A—hematologic cancer	4.08e-06	8.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	4.08e-06	8.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTEN—hematologic cancer	4.07e-06	8.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK8—hematologic cancer	4.07e-06	8.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—hematologic cancer	4.06e-06	8.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—hematologic cancer	4.06e-06	8.15e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYCS—hematologic cancer	4.04e-06	8.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	4.03e-06	8.1e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.01e-06	8.06e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK8—hematologic cancer	3.98e-06	8e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—hematologic cancer	3.97e-06	7.98e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EP300—hematologic cancer	3.96e-06	7.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF2—hematologic cancer	3.94e-06	7.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	3.89e-06	7.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EP300—hematologic cancer	3.88e-06	7.8e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SRC—hematologic cancer	3.86e-06	7.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAK2—hematologic cancer	3.78e-06	7.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SRC—hematologic cancer	3.78e-06	7.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—hematologic cancer	3.76e-06	7.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—hematologic cancer	3.75e-06	7.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—hematologic cancer	3.72e-06	7.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NRAS—hematologic cancer	3.71e-06	7.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	3.7e-06	7.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MDM2—hematologic cancer	3.69e-06	7.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—hematologic cancer	3.68e-06	7.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—hematologic cancer	3.64e-06	7.31e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NRAS—hematologic cancer	3.63e-06	7.29e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.61e-06	7.26e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MTOR—hematologic cancer	3.59e-06	7.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	3.59e-06	7.21e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.56e-06	7.15e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK3—hematologic cancer	3.55e-06	7.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK3—hematologic cancer	3.48e-06	6.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—hematologic cancer	3.45e-06	6.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—hematologic cancer	3.45e-06	6.92e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.45e-06	6.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	3.43e-06	6.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—hematologic cancer	3.38e-06	6.79e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—hematologic cancer	3.37e-06	6.78e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.37e-06	6.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	3.37e-06	6.76e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	3.33e-06	6.69e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—hematologic cancer	3.3e-06	6.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—hematologic cancer	3.3e-06	6.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—hematologic cancer	3.28e-06	6.59e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.27e-06	6.57e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.27e-06	6.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—hematologic cancer	3.21e-06	6.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JUN—hematologic cancer	3.21e-06	6.44e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—hematologic cancer	3.19e-06	6.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—hematologic cancer	3.13e-06	6.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	3.11e-06	6.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTEN—hematologic cancer	3.1e-06	6.23e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—hematologic cancer	3.08e-06	6.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	3.03e-06	6.09e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	3.03e-06	6.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EP300—hematologic cancer	2.96e-06	5.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—hematologic cancer	2.93e-06	5.89e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.89e-06	5.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.88e-06	5.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	2.87e-06	5.77e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—hematologic cancer	2.84e-06	5.7e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.8e-06	5.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—hematologic cancer	2.78e-06	5.58e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.77e-06	5.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.77e-06	5.56e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HRAS—hematologic cancer	2.71e-06	5.45e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HRAS—hematologic cancer	2.66e-06	5.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.65e-06	5.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—hematologic cancer	2.6e-06	5.22e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.58e-06	5.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.57e-06	5.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.55e-06	5.12e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—hematologic cancer	2.54e-06	5.11e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—hematologic cancer	2.51e-06	5.05e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.43e-06	4.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—hematologic cancer	2.4e-06	4.81e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.38e-06	4.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—hematologic cancer	2.35e-06	4.71e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.25e-06	4.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	2.19e-06	4.39e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.14e-06	4.29e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—hematologic cancer	2.12e-06	4.25e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—hematologic cancer	2.11e-06	4.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRAS—hematologic cancer	2.02e-06	4.06e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.02e-06	4.05e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.94e-06	3.89e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.86e-06	3.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.79e-06	3.59e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTEN—hematologic cancer	1.61e-06	3.23e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—EP300—hematologic cancer	1.53e-06	3.08e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.14e-06	2.28e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—hematologic cancer	9.27e-07	1.86e-05	CbGpPWpGaD
